Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
US FDA clears CStone’s IND application for novel trispecific antibody CS2009 to advance into phase II trial: Suzhou, China Tuesday, February 17, 2026, 11:00 Hrs [IST] CStone Pha ...
Despite being riddled with impurities and defects, solution-processed lead-halide perovskites are surprisingly efficient at ...
In the second PV development, announced simultaneously, a new III-V silicon PV module has achieved an efficiency of 31.3 percent, setting a record in its class, and is based on established, ...
It's about accountability and perspective.
CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase II clinical trial in patients ...
SHANNON, CLARE, IRELAND, February 5, 2026 /EINPresswire.com/ -- A new publication from Opto-Electronic Technology; DOI ...
In the global visual communication and packaging industries, the choice of printing substrate is not a mere technical specification—it is a strategic decision that directly impacts brand perception, ...
The Paul Scherrer Institute PSI is awarding PSI Founder Fellowships to Mohsen Sadr and Mohammadhossein Montazerian. The fellowships will support two business ideas based on PSI technologies: an ...
CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) to initiate ...
Behavior-Derived Intelligence Transforms How Recovery Is Supported, Measured, and Sustained Human behavior leaves a ...
What is common in population census, crime data, hate crimes, household consumption, India's real Gross Domestic Product (GDP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results